Showing results (91-100 of 128) with videos related to

Sort By:
Pageof 13
Kidney International Reports|February 23, 2026
Visceral Adipose Tissue Alters Podometrics and Renal Compensation After UninephrectomyChristopher Paschen, Maximilian C Koeller, Juliane Hennenberg, et al.
Clinical Genitourinary Cancer|July 5, 2011
Individual learning curve reduces the clinical value of urinary cytologyFrank Strittmatter, Alexander Buchner, Alexander Karl, et al.
Plos One|December 11, 2012
Silodosin inhibits noradrenaline-activated transcription factors Elk1 and SRF in human prostate smooth muscleMartin Hennenberg, Frank Strittmatter, Christer Beckmann, et al.
British Journal of Pharmacology|February 28, 2012
Inhibition of adrenergic human prostate smooth muscle contraction by the inhibitors of c-Jun N-terminal kinase, SP600125 and BI-78D3F Strittmatter, S Walther, C Gratzke, et al.
Urologia Internationalis|July 18, 2021
Choosing a Specialist: An Explanatory Study of Factors Influencing Patients in Choosing a UrologistAlexander Tamalunas, Alexander Buchner, Martin Hennenberg, et al.
Scientific Reports|February 10, 2025
Smooth muscle contractility of laser-enucleated prostate tissues and impacts of preoperative α<sub>1</sub>-blocker treatment in patients with and without catheterizationPatrick Keller, Sheng Hu, Laurenz Berger, et al.
ACS Chemical Biology|February 5, 2025
Blm10-Based Compounds Add to the Knowledge of How Allosteric Modulators Influence Human 20S ProteasomeJulia Witkowska, Małgorzata Giżyńska, Przemysław Karpowicz, et al.
European Journal of Pharmacology|November 4, 2010
Thromboxane A2 induces contraction of human prostate smooth muscle by Rho kinase- and calmodulin-dependent mechanismsFrank Strittmatter, Christian Gratzke, Philipp Weinhold, et al.
British Journal of Pharmacology|March 26, 2018
Inhibition of human prostate smooth muscle contraction by the LIM kinase inhibitors, SR7826 and LIMKi3Qingfeng Yu, Christian Gratzke, Yiming Wang, et al.
European Journal of Pharmacology|February 5, 2020
Onvansertib, a polo-like kinase 1 inhibitor, inhibits prostate stromal cell growth and prostate smooth muscle contraction, which is additive to inhibition by α<sub>1</sub>-blockersXiaolong Wang, Bingsheng Li, Anna Ciotkowska, et al.
Pageof 13